作者: Roy S Herbst , Paul Baas , Dong-Wan Kim , Enriqueta Felip , José L Pérez-Gracia
DOI: 10.1016/S0140-6736(15)01281-7
关键词:
摘要: Background Despite recent advances in the treatment of advanced non-small-cell lung cancer, there remains a need for effective treatments for progressive disease. We assessed the …